186 related articles for article (PubMed ID: 2411807)
1. Ia molecular localization of the DRw52 allodeterminant and the DRw52-like determinants defined by monoclonal antibodies.
Karr RW; Lipman LK; Alber C; Koning F; Goeken NE
J Immunol; 1985 Oct; 135(4):2642-6. PubMed ID: 2411807
[TBL] [Abstract][Full Text] [Related]
2. Quantitative and qualitative differences in HLA-DR molecules correlated with antigen-presentation capacity.
Bontrop R; Ottenhoff T; Van Miltenburg R; Elferink D; De Vries R; Giphart M
Eur J Immunol; 1986 Feb; 16(2):133-8. PubMed ID: 3485528
[TBL] [Abstract][Full Text] [Related]
3. T cells specific for different antigens express different HLA-D region products.
Schendel DJ; Johnson JP
Eur J Immunol; 1985 Dec; 15(12):1239-43. PubMed ID: 3878791
[TBL] [Abstract][Full Text] [Related]
4. Two-dimensional gel analysis of a second family of class II molecules by polymorphic HLA-DR4,5, and w9 monoclonal antibodies.
Maeda H; Hirata R; Okuyama M; Thompson A; Tohyama H
J Immunol; 1984 May; 132(5):2478-84. PubMed ID: 6201545
[TBL] [Abstract][Full Text] [Related]
5. The molecules recognized by anti-MT2 alloantisera and anti-MT2-like (DRw52) monoclonal antibodies are different.
Schiffenbauer J; Bono C; Schwartz BD
Hum Immunol; 1985 Apr; 12(4):223-33. PubMed ID: 3872866
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibodies to polymorphic epitopes on Ia antigens: three independent groups of determinants expressed on DRw6 homozygous cells.
Johnson JP; Wank R
Eur J Immunol; 1984 Aug; 14(8):739-44. PubMed ID: 6205884
[TBL] [Abstract][Full Text] [Related]
7. The complexity of HLA-DS molecules. A homozygous cell line expresses multiple HLA-DS alpha chains.
Karr RW; Alber C; Goyert SM; Silver J; Duquesnoy RJ
J Exp Med; 1984 May; 159(5):1512-31. PubMed ID: 6425448
[TBL] [Abstract][Full Text] [Related]
8. Immunochemical analysis of the Ia polymorphisms among the family of DR7-associated HLA-D specificities.
Karr RW
J Immunol; 1986 Feb; 136(3):999-1006. PubMed ID: 3510255
[TBL] [Abstract][Full Text] [Related]
9. Molecular relationships of the human B cell alloantigens, MT2, MB3, MT4, and DR5.
Karr RW; Kannapell CC; Stein JA; Gebel HM; Mann DL; Duquesnoy RJ; Fuller TC; Rodey GE; Schwartz BD
J Immunol; 1982 Apr; 128(4):1809-18. PubMed ID: 6174616
[TBL] [Abstract][Full Text] [Related]
10. Distinct HLA-DR epitopes and distinct families of HLA-Dr molecules defined by 15 monoclonal antibodies (mAb) either anti-DR or allo-anti-Iak cross-reacting with human DR molecule. I. Cross-inhibition studies of mAb cell surface fixation and differential binding of mAb to detergent-solubilized HLA molecules immobilized to a solid phase by a first mAb.
Rebai N; Malissen B; Pierres M; Accolla RS; Corte G; Mawas C
Eur J Immunol; 1983 Feb; 13(2):106-11. PubMed ID: 6187579
[TBL] [Abstract][Full Text] [Related]
11. Antigenic heterogeneity of human colorectal cancer cell lines analyzed by a panel of monoclonal antibodies. I. Heterogeneous expression of Ia-like and HLA-like antigenic determinants.
MacLean GD; Seehafer J; Shaw AR; Kieran MW; Longenecker BM
J Natl Cancer Inst; 1982 Aug; 69(2):357-64. PubMed ID: 6180206
[TBL] [Abstract][Full Text] [Related]
12. Complexity of the supertypic HLA-DRw53 specificity: two distinct epitopes differentially expressed on one or all of the DR beta-chains depending on the HLA-DR allotype.
Knowles RW; Flomenberg N; Horibe K; Winchester R; Radka SF; Dupont B
J Immunol; 1986 Oct; 137(8):2618-26. PubMed ID: 2428870
[TBL] [Abstract][Full Text] [Related]
13. Molecular identifications of HLA-DR4, MT3, and TB21 antigens on HLA-DR4 homozygous B cell lines.
Maeda H; Hirata R
J Immunol; 1984 Feb; 132(2):574-7. PubMed ID: 6418807
[TBL] [Abstract][Full Text] [Related]
14. Two distinct class II molecules encoded by the genes within HLA-DR subregion of HLA-Dw2 and Dw12 can act as stimulating and restriction molecules.
Sone T; Tsukamoto K; Hirayama K; Nishimura Y; Takenouchi T; Aizawa M; Sasazuki T
J Immunol; 1985 Aug; 135(2):1288-98. PubMed ID: 3159789
[TBL] [Abstract][Full Text] [Related]
15. Separation of three class II antigens from a homozygous human B cell line.
Shackelford DA; Lampson LA; Strominger JL
J Immunol; 1983 Jan; 130(1):289-96. PubMed ID: 6600185
[TBL] [Abstract][Full Text] [Related]
16. [Monoclonal antibodies against determinants on human MHC class II antigens].
Eichler W; Seifert M; Fiebig H
Allerg Immunol (Leipz); 1990; 36(4):309-20. PubMed ID: 1711285
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibodies to HLA-DP, DQ, and DR determinants: functional effects on the activation and proliferation of normal and EBV-transformed B cells.
Howard DR; Eaves AC; Takei F
Exp Hematol; 1986 Oct; 14(9):887-95. PubMed ID: 2428652
[TBL] [Abstract][Full Text] [Related]
18. Analysis of HLA-DR antigens by using monoclonal antibodies: recognition of conformational differences in biosynthetic intermediates.
Shackelford DA; Lampson LA; Strominger JL
J Immunol; 1981 Oct; 127(4):1403-10. PubMed ID: 6944380
[TBL] [Abstract][Full Text] [Related]
19. Two-dimensional gel analysis of the polypeptides precipitated by a polymorphic HLA-DR1,2,w6 monoclonal antibody: evidence for a third locus.
De Kretser TA; Crumpton MJ; Bodmer JG; Bodmer WF
Eur J Immunol; 1982 Jul; 12(7):600-6. PubMed ID: 6811289
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms within the HLA-DRw6 haplotype. II. Protein charge heterogeneity reflects MLC subtyping of HLA-DRw6 homozygous cells.
Bosch ML; Termijtelen A; Gerrets R; Schreuder GM; Bontrop RE; Giphart MJ
Immunogenetics; 1985; 22(1):23-33. PubMed ID: 2410359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
